Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
Acar
J
J
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001705:Bioprosthesis; D004305:Dose-Response Relationship, Drug; D006349:Heart Valve Diseases / Q000097:blood / Q000401:mortality / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D011183:Postoperative Complications / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D011474:Prosthesis Design; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000401:mortality / Q000517:prevention & control*
D000925:Anticoagulants